Works matching IS 02770008 AND DT 2024 AND VI 44 AND IP 5

Results: 8

Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary

Published in:

Pharmacotherapy, 2024, v. 44, n. 5, p. 354, doi. 10.1002/phar.2913

By:

Cluck, David B.;
Chastain, Daniel B.;
Murray, Milena;
Durham, Spencer H.;
Chahine, Elias B.;
Derrick, Caroline;
Dumond, Julie B.;
Hester, E. Kelly;
Jeter, Sarah B.;
Johnson, Melissa D.;
Kilcrease, Christin;
Kufel, Wesley D.;
Kwong, Jeffrey;
Ladak, Amber F.;
Patel, Nimish;
Pérez, Sarah E.;
Poe, Jonell B.;
Bolch, Charlotte;
Thomas, Ian;
Asiago‐Reddy, Elizabeth

Publication type:

Article

Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy

Published in:

Pharmacotherapy, 2024, v. 44, n. 5, p. 360, doi. 10.1002/phar.2914

By:

Cluck, David B.;
Chastain, Daniel B.;
Murray, Milena;
Durham, Spencer H.;
Chahine, Elias B.;
Derrick, Caroline;
Dumond, Julie B.;
Hester, E. Kelly;
Jeter, Sarah B.;
Johnson, Melissa D.;
Kilcrease, Christin;
Kufel, Wesley D.;
Kwong, Jeffrey;
Ladak, Amber F.;
Patel, Nimish;
Pérez, Sarah E.;
Poe, Jonell B.;
Bolch, Charlotte;
Thomas, Ian;
Asiago‐Reddy, Elizabeth

Publication type:

Article

Comment on "Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution".

Published in:

Pharmacotherapy, 2024, v. 44, n. 5, p. 409, doi. 10.1002/phar.2918

By:

Zhang, Yongyi;
Zhang, Qiushun;
Zhang, Junchen

Publication type:

Article

Issue Information.

Published in:: Pharmacotherapy, 2024, v. 44, n. 5, p. 349, doi. 10.1002/phar.2694
Publication type:: Article

Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta‐analysis.

Published in:

Pharmacotherapy, 2024, v. 44, n. 5, p. 394, doi. 10.1002/phar.2925

By:

White, C. Michael;
Caroti, Kimberly Snow;
Bessada, Youssef;
Hernandez, Adrian V.;
Baker, William L.;
Dobesh, Paul P.;
van Haalen, Heleen;
Rhodes, Kirsty;
Coleman, Craig I.

Publication type:

Article

Expert consensus recommendations for innovative antiretroviral drugs.

Published in:

Pharmacotherapy, 2024, v. 44, n. 5, p. 352, doi. 10.1002/phar.2924

By:

DeVane, C. Lindsay

Publication type:

Article

Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database.

Published in:

Pharmacotherapy, 2024, v. 44, n. 5, p. 383, doi. 10.1002/phar.2920

By:

Sarker, Jyotirmoy;
Carkovic, Emir;
Ptaszek, Karolina;
Lee, Todd A.

Publication type:

Article

Response to comment on "Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution".

Published in:

Pharmacotherapy, 2024, v. 44, n. 5, p. 411, doi. 10.1002/phar.2919

By:

Price, Lily;
Garrity, Lisa;
Stiehl, Sarah

Publication type:

Article